With the recent new additions to Osteoporosis Canada’s FLS Registry, there are now 52 FLSs in Canada.

On behalf of Osteoporosis Canada’s Scientific Advisory Consultants and Osteoporosis Canada, we would like to announce this year’s Lindy Fraser Award winner as chosen by the members of the SAC. […]

SAC Members and Research MD, MSC, PHD AhmedNegm Dr. Ahmed Negm is a trained orthopedic surgeon with additional training in health research and rehabilitation sciences. Following his undergraduate medical training […]

LIVING WELL WITH OSTEOPOROSIS Managing osteoporosis to live a full and active life You Are Not Alone It is common to feel anxious about your health or lifestyle when diagnosed […]

HORMONE THERAPY (HT) Estrogen plays such an important role in maintaining bone. Hormone Therapy (HT) or estrogen/progesterone, is commonly used to relieve the symptoms of menopause. However, because estrogen plays […]

PARATHYROID HORMONE (PTH) A new class of osteoporosis treatments called bone formation agents Parathyroid hormone analogues belong to a class of osteoporosis medications which can promote bone growth. In Canada, […]

Members of Osteoporosis Canada’s Scientific Advisory Council would like announce this year’s Lindy Fraser Award winner as chosen by the members of the SAC. Osteoporosis Canada established this award in 1993 […]

BISPHOSPHONATES The most common family of drugs used to treat osteoporosis Bisphosphonates are the most common family of drugs used to treat osteoporosis. They are part of the group of […]

Prepared and reviewed by members of the Scientific Advisory Council of Osteoporosis Canada • Dr. Rick Adachi, Rheumatologist, McMaster University • Dr. Robert Josse, Endocrinologist, University of Toronto • Dr. […]